Rhenman & Partners Asset Management AB as of March 31, 2016
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 92 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 3.3 | $17M | 121k | 139.22 | |
| Gilead Sciences (GILD) | 3.3 | $17M | 180k | 91.86 | |
| BioMarin Pharmaceutical (BMRN) | 3.1 | $16M | 190k | 82.48 | |
| Eli Lilly & Co. (LLY) | 2.8 | $14M | 195k | 72.01 | |
| Pfizer (PFE) | 2.8 | $14M | 475k | 29.64 | |
| Alkermes (ALKS) | 2.8 | $14M | 405k | 34.19 | |
| Incyte Corporation (INCY) | 2.5 | $12M | 170k | 72.47 | |
| Celgene Corporation | 2.4 | $12M | 120k | 100.09 | |
| Abiomed | 2.4 | $12M | 125k | 94.81 | |
| Allergan | 2.2 | $11M | 42k | 268.02 | |
| CVS Caremark Corporation (CVS) | 2.2 | $11M | 105k | 103.73 | |
| Medtronic (MDT) | 2.0 | $10M | 137k | 75.00 | |
| St. Jude Medical | 2.0 | $9.9M | 180k | 55.00 | |
| Biogen Idec (BIIB) | 2.0 | $9.9M | 38k | 260.32 | |
| Zimmer Holdings (ZBH) | 1.9 | $9.7M | 91k | 106.63 | |
| CIGNA Corporation | 1.9 | $9.5M | 69k | 137.25 | |
| Bristol Myers Squibb (BMY) | 1.8 | $9.1M | 142k | 63.88 | |
| Laboratory Corp. of America Holdings (LH) | 1.7 | $8.8M | 75k | 117.13 | |
| Centene Corporation (CNC) | 1.7 | $8.7M | 142k | 61.57 | |
| Medivation | 1.7 | $8.6M | 187k | 45.98 | |
| Walgreen Boots Alliance (WBA) | 1.7 | $8.4M | 100k | 84.24 | |
| Hca Holdings (HCA) | 1.6 | $8.1M | 104k | 78.05 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $7.8M | 125k | 62.77 | |
| Perrigo Company (PRGO) | 1.6 | $7.8M | 61k | 127.93 | |
| UnitedHealth (UNH) | 1.5 | $7.7M | 60k | 128.90 | |
| Cardinal Health (CAH) | 1.5 | $7.5M | 92k | 81.95 | |
| Aetna | 1.5 | $7.5M | 67k | 112.34 | |
| Abbvie (ABBV) | 1.5 | $7.4M | 130k | 57.12 | |
| Express Scripts Holding | 1.4 | $7.3M | 106k | 68.69 | |
| Endo International (ENDPQ) | 1.4 | $7.3M | 260k | 28.15 | |
| Nektar Therapeutics (NKTR) | 1.4 | $7.2M | 525k | 13.75 | |
| Amgen (AMGN) | 1.3 | $6.7M | 45k | 149.93 | |
| Anthem (ELV) | 1.3 | $6.5M | 47k | 139.00 | |
| McKesson Corporation (MCK) | 1.2 | $6.3M | 40k | 157.25 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $6.2M | 78k | 79.49 | |
| Cooper Companies | 1.2 | $6.2M | 40k | 153.98 | |
| AmerisourceBergen (COR) | 1.1 | $5.5M | 63k | 86.56 | |
| Dex (DXCM) | 1.0 | $5.1M | 75k | 67.91 | |
| Cepheid | 1.0 | $5.0M | 150k | 33.36 | |
| Humana (HUM) | 1.0 | $4.9M | 27k | 182.96 | |
| Edwards Lifesciences (EW) | 1.0 | $4.9M | 55k | 88.22 | |
| Cerner Corporation | 0.9 | $4.6M | 86k | 52.97 | |
| Keryx Biopharmaceuticals | 0.9 | $4.4M | 950k | 4.67 | |
| Regeneron Pharmaceuticals (REGN) | 0.9 | $4.3M | 12k | 360.42 | |
| Zeltiq Aesthetics | 0.9 | $4.3M | 160k | 27.16 | |
| Community Health Systems (CYH) | 0.8 | $4.2M | 225k | 18.51 | |
| Supernus Pharmaceuticals (SUPN) | 0.8 | $4.1M | 270k | 15.25 | |
| Halozyme Therapeutics (HALO) | 0.8 | $4.1M | 431k | 9.47 | |
| Jazz Pharmaceuticals (JAZZ) | 0.8 | $3.9M | 30k | 130.57 | |
| Ariad Pharmaceuticals | 0.8 | $3.8M | 600k | 6.39 | |
| Becton, Dickinson and (BDX) | 0.8 | $3.8M | 25k | 151.84 | |
| Livanova Plc Ord (LIVN) | 0.8 | $3.8M | 70k | 53.99 | |
| Endologix | 0.7 | $3.6M | 435k | 8.36 | |
| Radius Health | 0.7 | $3.3M | 105k | 31.44 | |
| Horizon Pharma | 0.7 | $3.3M | 200k | 16.57 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $3.2M | 115k | 27.80 | |
| HeartWare International | 0.6 | $3.1M | 100k | 31.42 | |
| Omnicell (OMCL) | 0.6 | $3.1M | 110k | 27.87 | |
| Lion Biotechnologies | 0.6 | $3.0M | 600k | 5.08 | |
| Cempra | 0.6 | $3.0M | 171k | 17.52 | |
| Revance Therapeutics (RVNC) | 0.6 | $3.0M | 170k | 17.46 | |
| Dynavax Technologies (DVAX) | 0.6 | $2.9M | 150k | 19.24 | |
| Insulet Corporation (PODD) | 0.5 | $2.7M | 82k | 33.16 | |
| Xencor (XNCR) | 0.5 | $2.7M | 200k | 13.42 | |
| Exelixis (EXEL) | 0.5 | $2.6M | 650k | 4.00 | |
| Chimerix (CMRX) | 0.5 | $2.6M | 500k | 5.11 | |
| Ionis Pharmaceuticals (IONS) | 0.5 | $2.6M | 64k | 40.50 | |
| Esperion Therapeutics (ESPR) | 0.5 | $2.5M | 150k | 16.91 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $2.5M | 40k | 63.30 | |
| Fibrogen (FGEN) | 0.5 | $2.4M | 114k | 21.29 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $2.4M | 60k | 39.55 | |
| Macrogenics (MGNX) | 0.5 | $2.3M | 120k | 18.75 | |
| Portola Pharmaceuticals | 0.4 | $2.1M | 105k | 20.40 | |
| Pacira Pharmaceuticals (PCRX) | 0.4 | $2.1M | 40k | 52.98 | |
| Hologic (HOLX) | 0.4 | $2.1M | 60k | 34.50 | |
| Achillion Pharmaceuticals | 0.4 | $2.1M | 266k | 7.72 | |
| Tandem Diabetes Care | 0.4 | $1.8M | 209k | 8.71 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $1.8M | 850k | 2.08 | |
| Catabasis Pharmaceuticals | 0.3 | $1.7M | 345k | 5.04 | |
| Anthera Pharmaceutcls | 0.3 | $1.6M | 435k | 3.62 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $1.4M | 50k | 27.96 | |
| Regulus Therapeutics | 0.3 | $1.4M | 200k | 6.93 | |
| Tetraphase Pharmaceuticals | 0.3 | $1.4M | 300k | 4.63 | |
| Valeant Pharmaceuticals Int | 0.3 | $1.3M | 50k | 26.30 | |
| Array BioPharma | 0.2 | $1.1M | 370k | 2.95 | |
| Nevro (NVRO) | 0.2 | $1.1M | 20k | 56.25 | |
| Mirati Therapeutics | 0.2 | $1.1M | 50k | 21.40 | |
| Avalanche Biotechnologies In | 0.2 | $796k | 154k | 5.17 | |
| Orexigen Therapeutics | 0.1 | $672k | 1.2M | 0.56 | |
| Ocular Therapeutix (OCUL) | 0.1 | $386k | 40k | 9.65 | |
| Bind Therapeutics | 0.1 | $294k | 134k | 2.20 | |
| Threshold Pharmaceuticals | 0.0 | $93k | 202k | 0.46 |
